• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

隧道型化脓性汗腺炎:具有特定分子和遗传特征的活跃炎症实体——一篇叙述性综述。

Tunnels in Hidradenitis Suppurativa: Active Inflammatory Entities with Specific Molecular and Genetic Profiles - A Narrative Review.

机构信息

Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland.

Department of Dermatology, Hospital de Manises, Valencia, Spain.

出版信息

Dermatology. 2023;239(3):323-327. doi: 10.1159/000529848. Epub 2023 Feb 23.

DOI:10.1159/000529848
PMID:36822156
Abstract

BACKGROUND

Hidradenitis suppurativa (HS) is a chronic, inflammatory, debilitating disorder of the pilosebaceous unit. Dermal tunnels, sinus tracts, or fistulas are unique features of HS. One may hypothesize that HS tunnels remain active and may contribute to inflammation and disease severity.

SUMMARY

Increased inflammatory infiltrate with an increased number and densities of immune cells was reported in HS tunnels. Moreover, significantly higher levels of IL-36, Il-17A, IL-17C, IL-17F, and CXCL8 mRNA compared to non-tunnel HS skin were found. Furthermore, in the lumen, a proliferative gelatinous mass consisting of inflammatory cells with similar cytokine levels as inflammatory HS lesions was found. It was also proven that HS sinus tracts are often colonized by Porphyromonas spp. and Prevotella spp. with a tendency to biofilm creation. The genetic profile of HS tunnels varies from non-tunnel HS skin, with upregulation of pro-inflammatory and downregulation of anti-inflammatory genes. Lastly, treatment with newly developed drugs targeting different subunits of IL-17 seems promising in decreasing dermal tunnel drainage and in the resolution of sinus tracts. Moreover, a higher percentage of patients treated with these drugs achieved HiSCR75 and HiSCR90.

摘要

背景

化脓性汗腺炎(HS)是一种慢性、炎症性、使人虚弱的毛囊皮脂腺单位疾病。皮肤隧道、窦道或瘘管是 HS 的独特特征。人们可能假设 HS 隧道仍然活跃,并可能导致炎症和疾病严重程度增加。

摘要

研究报告称,HS 隧道中存在更多数量和密度的免疫细胞,炎症浸润增加。此外,与非隧道 HS 皮肤相比,隧道 HS 皮肤中发现的 IL-36、Il-17A、IL-17C、IL-17F 和 CXCL8mRNA 水平显著更高。此外,在管腔中,发现了由具有与炎症性 HS 病变相似细胞因子水平的炎症细胞组成的增生胶状物质。还证明 HS 窦道通常被卟啉单胞菌属和普雷沃菌属定植,且具有生物膜形成的趋势。HS 隧道的遗传特征与非隧道 HS 皮肤不同,促炎基因上调,抗炎基因下调。最后,针对不同 IL-17 亚单位开发的新型药物治疗在减少皮肤隧道引流和窦道消退方面似乎很有前景。此外,用这些药物治疗的患者中,有更高比例的患者达到了 HiSCR75 和 HiSCR90。

相似文献

1
Tunnels in Hidradenitis Suppurativa: Active Inflammatory Entities with Specific Molecular and Genetic Profiles - A Narrative Review.隧道型化脓性汗腺炎:具有特定分子和遗传特征的活跃炎症实体——一篇叙述性综述。
Dermatology. 2023;239(3):323-327. doi: 10.1159/000529848. Epub 2023 Feb 23.
2
Clinical, microbiological, immunological and imaging characteristics of tunnels and fistulas in hidradenitis suppurativa and Crohn's disease.化脓性汗腺炎和克罗恩病窦道和瘘管的临床、微生物学、免疫学和影像学特征。
Exp Dermatol. 2020 Feb;29(2):118-123. doi: 10.1111/exd.14036. Epub 2019 Oct 1.
3
The microbiome of tunnels in hidradenitis suppurativa patients.隧道内微生物组与化脓性汗腺炎患者
J Eur Acad Dermatol Venereol. 2019 Sep;33(9):1775-1780. doi: 10.1111/jdv.15597. Epub 2019 May 6.
4
Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.皮肤科和性病科在莫斯塔尔临床医院用阿达木单抗治疗两例化脓性汗腺炎。
Acta Dermatovenerol Croat. 2021 Jul;29(2):108-110.
5
Bimekizumab for the treatment of hidradenitis suppurativa.比美吉珠单抗治疗化脓性汗腺炎。
Immunotherapy. 2024;16(16-17):1005-1013. doi: 10.1080/1750743X.2024.2401308. Epub 2024 Sep 19.
6
Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa: A Phase 2, Double-blind, Placebo-Controlled Randomized Clinical Trial.比美吉珠单抗治疗中重度化脓性汗腺炎的疗效和安全性:一项 2 期、双盲、安慰剂对照随机临床试验。
JAMA Dermatol. 2021 Nov 1;157(11):1279-1288. doi: 10.1001/jamadermatol.2021.2905.
7
Single-cell transcriptomics suggest distinct upstream drivers of IL-17A/F in hidradenitis versus psoriasis.单细胞转录组学表明,大汗腺炎和银屑病中 IL-17A/F 的上游驱动因素不同。
J Allergy Clin Immunol. 2023 Sep;152(3):656-666. doi: 10.1016/j.jaci.2023.05.012. Epub 2023 Jun 2.
8
Epithelialized tunnels are a source of inflammation in hidradenitis suppurativa.上皮化隧道是化脓性汗腺炎炎症的一个来源。
J Allergy Clin Immunol. 2021 Jun;147(6):2213-2224. doi: 10.1016/j.jaci.2020.12.651. Epub 2021 Feb 3.
9
High inflammation in hidradenitis suppurativa extends to perilesional skin and can be subdivided by lipocalin-2 expression.化脓性汗腺炎中的高炎症延伸至皮损周围皮肤,并可以通过脂联素-2 的表达进行细分。
J Allergy Clin Immunol. 2022 Jan;149(1):135-144.e12. doi: 10.1016/j.jaci.2021.05.027. Epub 2021 Jun 1.
10
The anti-inflammatory potency of biologics targeting tumour necrosis factor-α, interleukin (IL)-17A, IL-12/23 and CD20 in hidradenitis suppurativa: an ex vivo study.靶向肿瘤坏死因子-α、白细胞介素 (IL)-17A、IL-12/23 和 CD20 的生物制剂在化脓性汗腺炎中的抗炎效力:一项离体研究。
Br J Dermatol. 2019 Aug;181(2):314-323. doi: 10.1111/bjd.17641. Epub 2019 Apr 12.

引用本文的文献

1
Neutrophil Extracellular Traps Are Widely Distributed Across Lesional and Perilesional Hidradenitis Suppurativa Skin, and Elevated Serum NET Markers Associate With Moderate to Severe HS Disease.中性粒细胞胞外诱捕网广泛分布于化脓性汗腺炎的皮损及皮损周围皮肤,血清中NET标志物升高与中度至重度化脓性汗腺炎疾病相关。
Int J Dermatol. 2025 Jul;64(7):1234-1241. doi: 10.1111/ijd.17706. Epub 2025 Mar 13.
2
Therapeutic burden in hidradenitis suppurativa: a cross-sectional study of 557 patients.化脓性汗腺炎的治疗负担:一项对557例患者的横断面研究。
Int J Dermatol. 2025 Mar;64(3):539-545. doi: 10.1111/ijd.17517. Epub 2024 Oct 15.
3
The NLRP3 Inflammasome Gene Is Overexpressed in Hidradenitis Suppurativa Lesions: A Preliminary Study on the Role of Pyroptosis in Disease Pathogenesis.
NLRP3炎性小体基因在化脓性汗腺炎病变中过表达:细胞焦亡在疾病发病机制中作用的初步研究
Curr Issues Mol Biol. 2024 Mar 16;46(3):2544-2552. doi: 10.3390/cimb46030161.
4
An Atlas of the Hidradenitis Suppurativa Transcriptome.化脓性汗腺炎转录组图谱
Dermatol Ther (Heidelb). 2024 Feb;14(2):409-420. doi: 10.1007/s13555-023-01083-y. Epub 2024 Jan 6.
5
Clinical Features and Response to Treatment in Elderly Subjects Affected by Hidradenitis Suppurativa: A Cohort Study.化脓性汗腺炎老年患者的临床特征及治疗反应:一项队列研究
J Clin Med. 2023 Dec 18;12(24):7754. doi: 10.3390/jcm12247754.
6
Targeting Metabolic Syndrome in Hidradenitis Suppurativa by Phytochemicals as a Potential Complementary Therapeutic Strategy.针对化脓性汗腺炎的代谢综合征的植物化学物质作为一种潜在的补充治疗策略。
Nutrients. 2023 Aug 30;15(17):3797. doi: 10.3390/nu15173797.